• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Calistoga

edit

Biopharmaceutical company focused on developing medicines that take advantage of the PI3 kinase pathway to improve the health of patients suffering from cancer and inflammatory diseases. Based in Seattle, WA.

Milestones

edit

• 
  Calistoga received $30M in Series B funding. (6/14/09)
  Posted 6/16/09 at 8:42am

Videos

Screenshots

edit

Above: Home Page
Uploaded: 6/16/09

Sources

1. Calistoga Pharmaceuticals, Inc.: Series B $30M (onbiovc.com) [edit]